SEARCH

SEARCH BY CITATION

References

  • 1
    Noel LP, Clarke WN, Peacocke TA. Periorbital and orbital cellulitis in childhood. Can J Ophthalmol 1981; 16(4): 178 80.
  • 2
    Weiss A, Friendly D, Eglin K, Chang M, Gold B. Bacterial periorbital and orbital cellulitis in childhood. Ophthalmology 1983; 90(3): 195 203.
  • 3
    Ricos Furio G, Gibert Agullo A, Youssef Fasheh W. Etmoiditis aguda. Revisión de 38 casos. An Esp Pediatr 1996; 44(2): 129 32.
  • 4
    Donahue SP & Schwartz G. Preseptal and orbital cellulitis in childhood. A changing microbiologic spectrum. Ophthalmology 1998; 105(10): 1902 6.
  • 5
    Brook I, Friedman EM, Rodriguez WJ, Controni G. Complications of sinusitis in children. Pediatrics 1980; 66(4): 568 72.
  • 6
    Page EL & Wiatrak BJ. Endoscopic vs external drainage of orbital subperiosteal abscess. Arch Otolaryngol Head Neck Surg 1996; 122(7): 737 40.
  • 7
    Shayegani A, MacFarlane D, Kazim M, Grossman ME. Streptococcal gangrene of the eyelids and orbit. Am J Ophthalmol 1995; 120(6): 784 92.
  • 8
    Ingraham HJ, Ryan ME, Burns JT et al. Streptococcal preseptal cellulitis complicated by the toxic Streptococcus syndrome. Ophthalmology 1995; 102(8): 1223 6.
  • 9
    Pannier M, Bouchot-Hermouet M, Lavergne-Hepner D, Hepner Y, David A, Stalder JF. Beta-hemolytic streptococcal periorbital necrotizing fasciitis in a child. Ann Chir Plast Esthet 1991; 36(1): 75 8.
  • 10
    Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952; 13: 389 99.
  • 11
    Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158(1): 23 8.
  • 12
    Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993; 91(2): 602 7.
  • 13
    Barry W, Hudgins L, Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 1992; 267(24): 3315 16.